Facebook Linkedin RSS Twitter Youtube
Home 2011

Enzyme replacement therapy

Oxford BioMedica and ImaginAb Ally to Develop 5T4 Antibody-Based Cancer Imaging Agent
Cancer

Oxford BioMedica and ImaginAb Ally to Develop 5T4 Antibody-Based Cancer Imaging Agent

Synageva Raises $25M Through Private Placement with Existing Investors
Drug Discovery

Synageva Raises $25M Through Private Placement with Existing Investors

Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy
Bioprocessing

Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy

GSK Pays Amicus $30M Up Front for Phase III Fabry Disease Drug
Drug Discovery

GSK Pays Amicus $30M Up Front for Phase III Fabry Disease Drug

Protein Production Continues to Post Gains
Insights

Protein Production Continues to Post Gains

Shire Gains EC Nod for Gaucher Disease Treatment
Drug Discovery

Shire Gains EC Nod for Gaucher Disease Treatment

Lilly Buys Alnara to Acquire Non-Porcine ERT for Pancreatic Insufficiency
Drug Discovery

Lilly Buys Alnara to Acquire Non-Porcine ERT for Pancreatic Insufficiency

Critical Biologics to Use Scarab’s Clean Genome E. coli for Production of Phase II Gelsolin Replacement Therapy
Bioprocessing

Critical Biologics to Use Scarab’s Clean Genome E. coli for Production of Phase II Gelsolin Replacement Therapy

Shire’s Gaucher Disease Therapy Gets FDA Green Light
News

Shire’s Gaucher Disease Therapy Gets FDA Green Light

Alnara Scores $35M to Push NDA Filing for Nonporcine Pancreatic Enzyme Replacement Therapy
Industry News

Alnara Scores $35M to Push NDA Filing for Nonporcine Pancreatic Enzyme Replacement Therapy

1234Page 3 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.